GSK plc ( GSK) - Key Metrics
GSK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $4.40 | $0.76 | $1.39 | $1.20 |
| 2026Q2 | $4.19 | $0.22 | $1.26 | $1.10 |
| 2026Q1 | $3.79 | $0.86 | $0.57 | $0.35 |
| 2025Q4 | $4.29 | $0.32 | $1.01 | $0.73 |
| 2025Q3 | $4.24 | $1 | $1.50 | $1.29 |
GSK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 44.40% | 11.95 |
| 2026Q2 | 167.48% | 44.92 |
| 2026Q1 | 37.02% | 12.13 |
| 2025Q4 | 98.82% | 28.43 |
| 2025Q3 | 44.98% | 8.02 |
GSK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 3.32% | 0.93% |
| 2026Q2 | 2.78% | 0.92% |
| 2026Q1 | 0.83% | 0.77% |
| 2025Q4 | 2.02% | 0.86% |
| 2025Q3 | 4.02% | 1.40% |
GSK
Price: $48.26
Dividend Yield: 3.70%
Forward Dividend Yield: 3.78%
Payout Ratio: 52.47%
Dividend Per Share: 1.81 USD
Earnings Per Share: 2.87 USD
P/E Ratio: 17.12
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 98.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: -1.69%
DGR5: -5.85%
DGR10: -4.42%
DGR20: 0.33%